28 results
424B5
PHIO
Phio Pharmaceuticals Corp
1 Jun 23
Prospectus supplement for primary offering
5:00pm
and adversely affected by the coronavirus pandemic;
our product candidates are in an early stage of development and may fail or experience significant delays
8-K
EX-99.1
PHIO
Phio Pharmaceuticals Corp
20 Apr 23
Phio Pharmaceuticals Announces $2 Million Registered Direct
2:53pm
and operations by the ongoing coronavirus pandemic, military conflict between Ukraine and Russia, inflationary pressures, rising interest rates, recession
8-K
EX-99.2
PHIO
Phio Pharmaceuticals Corp
20 Apr 23
Phio Pharmaceuticals Announces $2 Million Registered Direct
2:53pm
conditions, the impact to our business and operations by the ongoing coronavirus pandemic, military conflict between Ukraine and Russia, inflationary
424B5
PHIO
Phio Pharmaceuticals Corp
19 Apr 23
Prospectus supplement for primary offering
5:06pm
statements include, but are not limited to:
our business and operations may be materially and adversely affected by the coronavirus pandemic;
our product
8-K
EX-99.1
8vrrpz0vmns
18 Apr 23
Phio Pharmaceuticals Presents Preclinical Data Demonstrating Synergy-Enhanced in vivo Anti-Tumor Efficacy of PD-1/CTLA-4 Dual-Targeting INTASYL
7:55am
8-K
EX-99.1
udt bolel40
17 Apr 23
Phio Pharmaceuticals Presents Preclinical Study Showing PH-762 Induces Systemic Memory T Cell Mediators of Anti-Tumor Immunity
5:25pm
8-K
EX-99.1
bm3zl8
21 Dec 22
Phio Pharmaceuticals Announces New Clinical
4:30pm
8-K
EX-99.1
p76 wage07v0mpzw
10 Nov 22
Reports on Third Quarter 2022 Financial Results and Provides Business Update
5:05pm
8-K
EX-99.1
vhp9f16zj2 37mpnah44
11 Aug 22
Phio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update
5:00pm
8-K
EX-99.1
n3yo6qe8ek4 onrjk
12 May 22
Phio Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
5:00pm
8-K
EX-99.1
nk14r6evbieva
22 Mar 22
Phio Pharmaceuticals Reports 2021 Year End Financial Results and Provides Business Update
5:05pm
8-K
EX-99.1
zxdygvyi5 nrwmemcd
10 Nov 21
Phio Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update
4:40pm
8-K
EX-99.1
abitmmuy1e5yf2yipofs
12 Aug 21
Phio Pharmaceuticals Reports Second Quarter 2021
5:10pm